from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0499/-

LFCtreatmentdescriptionclass of inhibitor

-0.249

Amikacinug/mL Amikacintranslation

-0.519

Cap5-10ug/mL Capreomycintranslation

0.108

Rox10-50 ug/mL Roxithromycintranslation

-0.433

SM2-5 ug/mL Streptomycintranslation

-0.146

Tet5-10 ug/mL Tetracyclinetranslation

0.238

Rif0.2-5ug/mL Rifampicintranscription

0.447

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.166

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.501

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.249

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.500

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.131

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.075

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.983

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.988

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.676

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.508

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.265

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.196

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.114

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.111

KCN5-20 ug/mL Potassium cyaniderespiration

-0.037

NaN30.2-2 mM Sodium aziderespiration

0.009

Nigericin50 uM Nigericinrespiration

-0.219

TRC10-150 ug/mL Triclosanrespiration

-1.057

TRZ10-25 ug/mL Thioridazinerespiration

-1.333

Valinomycin0.5-10 uM Valinomycinrespiration

4.775

ZnSO42 mM ZnSO4respiration

0.744

menadione6-10 ug/mL Menadionerespiration

-0.151

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.042

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.005

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.215

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.087

NRP_1Non-replicating persistence stage 1dosRassociated

-0.622

Amp0.2mg/mL AmpicillincellWall

-0.212

Cephalexin20-100 ug/mL CephalexincellWall

0.043

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.209

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.079

EMB10-20 ug/mL EthambutolcellWall

0.028

Eta12-40 ug/mL EthionamidecellWall

0.192

INH0.2-0.4 ug/mL IsoniazidcellWall

0.007

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.458

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.116

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.057

BZA0.12 mg/mL BenzamidearomaticAmides

1.209

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.801

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.114

H2O24 mM hydrogen peroxideDNAdamaging

-0.170

Levo10 ug/mL LevofloxacinDNAdamaging

-0.264

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.206

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.176

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.168

UVUV-irradiationDNAdamaging

0.152

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.347

Antimycin12.5-50 ug/mL Antimycin A?

-0.157

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.310

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.262

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.095

PA8240.2-2 ug/mL PA-824?

-0.147

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.132

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.035

Verapamil50 uM Verapamil?

-0.255

mercaptoethanol2 mM 2-Mercaptoethanol?

0.028

methoxatin10-20 ug/mL Methoxatin?